SanofiSynthlabo News

Analyst Report ) reported a third-quarter net loss of $1.015 million, or 1 cent per share, which was much better than the Zacks Consensus Estimate of a loss of 23 cents.

For most of us, the very mention of "swine flu" brings about feelings of fear, or at the very least thoughts of fevers, congestion, annoying coughs and stuffy noses.

Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S. Prasco Laboratories announced today that it has entered into agreements with Winthrop U.S., a business of sanofi-aventis U.S., to provide sales support and distribution services ...

Merck CEO Richard Clark says his company is looking to do more deals than ever, perhaps "even try to double" the current rate of 50 per year.

" November 2, 2009 -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group , presented Safety of a Quadrivalent Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the Infectious Diseases Society of America this past weekend.

Nov 4, 2009 - Exelixis, Inc. announced today that thirteen abstracts related to the company's development candidates have been accepted for presentation at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held November 15-19 in Boston.

I last recommended that Fools take a look at consumer-staples company Clorox back in June.

Regeneron Pharmaceuticals Inc. filed Quarterly Report for the period ended 2009-09-30. Regeneron Pharmaceuticals Inc.

Main Category: Infectious Diseases / Bacteria / Viruses Also Included In: Pharma Industry / Biotech Industry Immune System / Vaccines Sanofi Pasteur, the vaccines division of sanofi-aventis Group , presented Safety of a Quadrivalent Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the ...

French drugmaker Sanofi-Aventis says it is promoting two high-ranking executives and adding a third to its executive committee.

Nearly a million people die from malaria each year because they cannot afford the most effective treatment and instead often buy old drugs to which the malaria parasite has become resistant, researchers said on Monday.

Alstom SA first-half sales rose 8% to 9.7 billion and net profit rose 7% to 562 million.

30 /PRNewswire-FirstCall/ --In order to facilitate an understanding of our operational performance, we comment on our adjusted income statement excluding selected items , a non-GAAP financial measure.

French drugmaker Sanofi-Aventis said Friday its third-quarter net income rose 6%, buoyed by a strong performance in emerging markets and a surge in global sales of the Lantus insulin drug.

Sanofi-Aventis raised its outlook for 2009 thanks to sales of swine flu vaccine and posted earnings per share growth that beat forecasts as competition from generics was offset by revenue growth for other drugs.

Sanofi-Aventis SA reported Friday a 6 percent rise in third-quarter profit and said strong sales of its vaccine against swine flu will drive earnings higher than expected for the full year.

Merck & Co., Inc. must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis S.A., and Schering-Plough must sell its assets related to significant drugs for nausea and vomiting in humans, in order for Schering-Plough to complete its proposed $41.1 billion acquisition of Merck, the Federal Trade Commission announced ...

Bristol-Myers Squibb posted a marked drop in third-quarter earnings early Thursday, due primarily to a massive gain taken during the 2008 quarter for the sale of its wound-care business.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

A unit of Sanofi-Aventis SA , Francea s biggest drugmaker, accused U.S. rival Hospira Inc.